Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

covid 19 yemen patientbeingmoved jacobburns 2020 Photograph by Diego Baravelli
Press release
Press release |
11 November 2020
COVID-19

MSF: Governments must demand pharma make all COVID-19 vaccine licensing deals public

MSF intervention in Rio, Praça da Cruz Vermelha Photograph by Mariana Abdalla
Press release
Press release |
03 November 2020
COVID-19

MSF welcomes Fiocruz’s step towards transparency of AstraZeneca deal

2 min
Staff checking on patients. These are usual rounds where doctors check on the progress of the patient accompanied with a counsellor to get insights into their interactions with the patient as well. Photograph by Garvit Nangia
Press release
Press release |
28 October 2020
COVID-19

MSF response to Gavi’s intent to purchase Sanofi-GSK COVID-19 vaccine candidate for the COVAX Facility

3 min
Nobuhle Titus, an MSF nurse technical support, packs sputum samples collected from a Luyanda site in the town of Vuma. Luyanda sites She collects and transports the samples from MSF’s Luyanda sites to the hospital where they are tested. Luyanda sites provide a link between patients and hospitals where patients can have sputum samples tested and receive information on TB and other diseases. This process makes the process of testing TB easier for patients who often stay far away from the hospital. Photograph by Tadeu Andre
Press release
Press release |
14 October 2020
Tuberculosis

MSF response to the release of WHO Global TB Report 2020

2 min
covid19_yemen_patientbeingmoved_jacobburns_2020_msf324285_3800px_0.jpg Photograph by Jacob Burns
Press release
Press release |
07 October 2020
COVID-19

In landmark move, India and South Africa propose no patents on COVID-19 medicines, tools during pandemic

4 min
An MSF Health Promoter speaks with people about how to keep safe during the COVID-19 pandemic. Photograph by Tadeu Andre
Press release
Press release |
03 August 2020
COVID-19

MSF applauds South Africa for championing health safeguards at meeting of WTO members

4 min
covid_conakry_genexpert_albertmasias_2020_msb19703_3800px Photograph by Albert Masias
Press release
Press release |
28 July 2020
COVID-19

COVID-19 test maker Cepheid overcharges and undersupplies WHO effort for developing countries

5 min
At MSF’s post-operative care hospital in Mosul (Iraq), infection and prevention control (IPC) measures are implemented. One of the pillars of IPC consists in cleaning, sterilizing and sanitizing. Here, an MSF nurse is preparing equipment prior to a surgery. Photograph by Mario Fawaz
Press release
Press release |
09 July 2020
Antimicrobial resistance

MSF response to global launch of: ‘A New Pharma Initiative takes on the Antibiotic Innovative Challenge’

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury